Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Type of study
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-26525379

ABSTRACT

Altered tissue fatty acid (FA) composition may affect mechanisms involved in the control of energy homeostasis, including central insulin actions. In rats fed either standard chow or a lard-enriched chow (high in saturated/low in polyunsaturated FA, HS-LP) for eight weeks, we examined the FA composition of blood, hypothalamus, liver, and retroperitoneal, epididymal and mesenteric adipose tissues. Insulin-induced hypophagia and hypothalamic signaling were evaluated after intracerebroventricular insulin injection. HS-LP feeding increased saturated FA content in adipose tissues and serum while it decreased polyunsaturated FA content of adipose tissues, serum, and liver. Hypothalamic C20:5n-3 and C20:3n-6 contents increased while monounsaturated FA content decreased. HS-LP rats showed hyperglycemia, impaired insulin-induced hypophagia and hypothalamic insulin signaling. The results showed that, upon HS-LP feeding, peripheral tissues underwent potentially deleterious alterations in their FA composition, whist the hypothalamus was relatively preserved. However, hypothalamic insulin signaling and hypophagia were drastically impaired. These findings suggest that impairment of hypothalamic insulin actions by HS-LP feeding was not related to tissue FA composition.


Subject(s)
Diet, High-Fat/adverse effects , Fatty Acids/metabolism , Hypothalamus/metabolism , Insulin Resistance , Intra-Abdominal Fat/metabolism , Liver/metabolism , Obesity/metabolism , Adiposity , Animals , Appetite Regulation , Dietary Fats/adverse effects , Fatty Acids/blood , Hyperglycemia/blood , Hyperglycemia/etiology , Hyperglycemia/metabolism , Hyperglycemia/pathology , Hypothalamus/pathology , Intra-Abdominal Fat/pathology , Liver/pathology , Male , Obesity/blood , Obesity/etiology , Obesity/pathology , Organ Size , Organ Specificity , Random Allocation , Rats, Wistar , Signal Transduction
2.
Braz. j. med. biol. res ; 47(9): 780-788, 09/2014. tab, graf
Article in English | LILACS | ID: lil-719321

ABSTRACT

Ginkgo biloba extract (GbE) has been indicated as an efficient medicine for the treatment of diabetes mellitus type 2. It remains unclear if its effects are due to an improvement of the insulin signaling cascade, especially in obese subjects. The aim of the present study was to evaluate the effect of GbE on insulin tolerance, food intake, body adiposity, lipid profile, fasting insulin, and muscle levels of insulin receptor substrate 1 (IRS-1), protein tyrosine phosphatase 1B (PTP-1B), and protein kinase B (Akt), as well as Akt phosphorylation, in diet-induced obese rats. Rats were fed with a high-fat diet (HFD) or a normal fat diet (NFD) for 8 weeks. After that, the HFD group was divided into two groups: rats gavaged with a saline vehicle (HFD+V), and rats gavaged with 500 mg/kg of GbE diluted in the saline vehicle (HFD+Gb). NFD rats were gavaged with the saline vehicle only. At the end of the treatment, the rats were anesthetized, insulin was injected into the portal vein, and after 90s, the gastrocnemius muscle was removed. The quantification of IRS-1, Akt, and Akt phosphorylation was performed using Western blotting. Serum levels of fasting insulin and glucose, triacylglycerols and total cholesterol, and LDL and HDL fractions were measured. An insulin tolerance test was also performed. Ingestion of a hyperlipidic diet promoted loss of insulin sensitivity and also resulted in a significant increase in body adiposity, plasma triacylglycerol, and glucose levels. In addition, GbE treatment significantly reduced food intake and body adiposity while it protected against hyperglycemia and dyslipidemia in diet-induced obesity rats. It also enhanced insulin sensitivity in comparison to HFD+V rats, while it restored insulin-induced Akt phosphorylation, increased IRS-1, and reduced PTP-1B levels in gastrocnemius muscle. The present findings suggest that G. biloba might be efficient in preventing and treating obesity-induced insulin signaling impairment.


Subject(s)
Animals , Male , Adiposity/drug effects , Dyslipidemias/drug therapy , Ginkgo biloba/chemistry , Obesity/drug therapy , Phytotherapy , Blood Glucose/analysis , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Diet, High-Fat/adverse effects , Dyslipidemias/metabolism , Eating/drug effects , Glucose Tolerance Test , Hypoglycemia/blood , Insulin Receptor Substrate Proteins/analysis , Insulin Resistance/physiology , Insulin/metabolism , Muscle, Skeletal/chemistry , Obesity/etiology , Plant Extracts/therapeutic use , Protein Tyrosine Phosphatase, Non-Receptor Type 1/analysis , Proto-Oncogene Proteins c-akt/analysis , Rats, Wistar , Signal Transduction/drug effects , Triglycerides/blood
3.
Braz J Med Biol Res ; 47(9): 780-8, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25075573

ABSTRACT

Ginkgo biloba extract (GbE) has been indicated as an efficient medicine for the treatment of diabetes mellitus type 2. It remains unclear if its effects are due to an improvement of the insulin signaling cascade, especially in obese subjects. The aim of the present study was to evaluate the effect of GbE on insulin tolerance, food intake, body adiposity, lipid profile, fasting insulin, and muscle levels of insulin receptor substrate 1 (IRS-1), protein tyrosine phosphatase 1B (PTP-1B), and protein kinase B (Akt), as well as Akt phosphorylation, in diet-induced obese rats. Rats were fed with a high-fat diet (HFD) or a normal fat diet (NFD) for 8 weeks. After that, the HFD group was divided into two groups: rats gavaged with a saline vehicle (HFD+V), and rats gavaged with 500 mg/kg of GbE diluted in the saline vehicle (HFD+Gb). NFD rats were gavaged with the saline vehicle only. At the end of the treatment, the rats were anesthetized, insulin was injected into the portal vein, and after 90s, the gastrocnemius muscle was removed. The quantification of IRS-1, Akt, and Akt phosphorylation was performed using Western blotting. Serum levels of fasting insulin and glucose, triacylglycerols and total cholesterol, and LDL and HDL fractions were measured. An insulin tolerance test was also performed. Ingestion of a hyperlipidic diet promoted loss of insulin sensitivity and also resulted in a significant increase in body adiposity, plasma triacylglycerol, and glucose levels. In addition, GbE treatment significantly reduced food intake and body adiposity while it protected against hyperglycemia and dyslipidemia in diet-induced obesity rats. It also enhanced insulin sensitivity in comparison to HFD+V rats, while it restored insulin-induced Akt phosphorylation, increased IRS-1, and reduced PTP-1B levels in gastrocnemius muscle. The present findings suggest that G. biloba might be efficient in preventing and treating obesity-induced insulin signaling impairment.


Subject(s)
Adiposity/drug effects , Dyslipidemias/drug therapy , Ginkgo biloba/chemistry , Obesity/drug therapy , Phytotherapy , Animals , Blood Glucose/analysis , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Diet, High-Fat/adverse effects , Dyslipidemias/metabolism , Eating/drug effects , Glucose Tolerance Test , Hypoglycemia/blood , Insulin/metabolism , Insulin Receptor Substrate Proteins/analysis , Insulin Resistance/physiology , Male , Muscle, Skeletal/chemistry , Obesity/etiology , Plant Extracts/therapeutic use , Protein Tyrosine Phosphatase, Non-Receptor Type 1/analysis , Proto-Oncogene Proteins c-akt/analysis , Rats, Wistar , Signal Transduction/drug effects , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...